Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proglumide in Management of Chronic Pancreatitis Symptoms and Pain
NCT05551858Phase 2Active, not recruiting
- Sponsor
- Georgetown University
- Start
- Nov 2022
- Primary completion
- Jun 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic pancreatitis (CP) comparing Placebo -> Proglumide with Proglumide (2 arms). Primary endpoints: Change in blood chemistry tests at 12 weeks and Adverse events at 12 weeks. Started Nov 2022; status: active, not recruiting.
02
Drugs
Proglumide
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NCT05551858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05551858.